Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
Submitted by
admin
on August 10, 2015 - 10:53am
Source:
BioPharma Dive
News Tags:
CVS
PCSK9 inhibitors
formulary
Sanofi
Regeneron
Praluent
Amgen
Repatha
Headline:
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
Do Not Allow Advertisers to Use My Personal information
